Research & Development
Pathology & AI
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.
September 22, 2023
BigOmics outlines expansion, omics pipeline
BigOmic’s plan includes providing a more complete pipeline for end-to-end analysis of transcriptomics and proteomics data, according to an interview with GenomeWeb.
August 28, 2023
Roche adds Navify digital solutions to its digital health portfolio at HLTH 2022
Roche announced that the Navify digital solutions brand will be added to its digital health portfolio, providing labs and healthcare providers access to optimization tools for digital infrastructure.
November 4, 2022
Software firms combine as CliniSys acquires ApolloLIMS
The move is part of an expansion plan by CliniSys to embrace digital diagnostics, leverage the cloud as part of the future of diagnostics, and enhance laboratory informatics. Current customers of ApolloLIMS will continue to be supported, but plans are that ApolloLIMS solutions will become integrated into the CliniSys product family over time.
April 12, 2022
Tempus launches pathology informatics, research platform
Edge launched on March 21 and includes digital pathology algorithms that help users predict the potential of biomarkers from patients whose samples are not usually analyzed, according to the firm.
April 10, 2022
CliniSys acquires Horizon Lab, combines with Sunquest
Together, the companies have more than 1,300 employees in 12 countries. The companies said that the newly formed group will enable improved public health outcomes through innovation in diagnostics and laboratory informatics technology.
January 17, 2022
Konica Minolta names new strategy, informatics officer
In his new role, Usuka will be responsible for identifying opportunities for the company to advance integrated diagnostics in predicting, diagnosing, and treating disease. Usuka joins Konica Minolta from McKinsey.
August 10, 2021
Survey: Scientists want to boost use of lab automation
In total, 74% of scientists reported that less than half of their lab operations are automated. Of those surveyed, 19% of respondents said that their labs are between 51% and 75% automated and only 6% reported an automation percentage over 76%.The most commonly used software and tools reported in the current survey were bioinformatics/cheminformatics, LIMSs, and specialized SDMSs. Researchers wanted to increase the use of electronic laboratory notebooks, SDMSs, and laboratory workflow automation systems in the future.When asked to select the top three benefits of lab automation and informatics, respondents reported the following:
May 24, 2021
BioMerieux debuts clinical informatics software
The Clarion software-as-a-service tool aids antimicrobial stewardship programs at labs and hospitals. The software provides critical infectious disease data and increased visibility for the value of diagnostics, the company noted.
November 22, 2020
BioInformatics releases more results from COVID-19 lab tracker survey
The first round of data from BioInformatics' COVID-19 Lab Closures Tracker survey revealed that 48% of academic and pharma/biotech labs that responded to the survey reported that they were closed. The results represent the first three weeks' worth of data collected from over 2,000 scientists.
April 19, 2020
Inspirata offers free remote pathology viewing amid COVID-19 outbreak
The company specializes in cancer informatics and digital pathology solutions. It said that its platform may be used by pathologists to submit slides and to upload images, which can then be shared with colleagues globally.
March 22, 2020
Qiagen, LabCorp expand partnership
The deal will involve the use of next-generation sequencing to identify genetic variants within inherited diseases, and it represents an expansion of LabCorp's Qiagen Clinical Insight (QCI) license, the companies said in a statement. With the arrangement, LabCorp said it will get a flexible platform that will allow it to move from large-scale to highly targeted test panels in clinical diagnostics and clinical studies of therapies and diagnostics.
November 20, 2019
Page 1 of 2